Open AccessAbstract CT266: Safety and efficacy of nimotuzumab in combination with chemotherapy in patients with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC): A phase II study
Author(s) -
Tao Hou,
Min Lü,
Xiayan Zhao,
Yan He,
Chunhong Hu,
Ping Liu
Publication year - 2020
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2020-ct266
Subject(s) - medicine , nimotuzumab , docetaxel , oncology , response evaluation criteria in solid tumors , mucositis , phases of clinical research , chemotherapy , adverse effect , clinical endpoint , head and neck cancer , head and neck squamous cell carcinoma , radiation therapy , gastroenterology , cancer , clinical trial , epidermal growth factor receptor